Connect with us

Health

Jessye Norman’s Family Sue Over Treatment That Allegedly Left Her Paralysed

Jessye Norman’s family sue over treatment that allegedly left her paralysed

She had a voice described as a “grand mansion of sound”, won four Grammy awards and thrilled audiences in the world’s opera house – but suddenly stopped performing in 2015.

When Jessye Norman died four years later at the age of 74, her family said she had passed away from septic shock and multi-organ failure secondary to complications of a spinal cord injury she had sustained in 2015. The circumstances surrounding the injury and disappearance from public life were never explained.

However, it can be revealed that Norman’s brother is suing two renowned doctors and a leading London private hospital for allegedly leaving her paralysed when she underwent surgery in 2015 to try and cure a longstanding and painful back problem.

James Howard Norman Sr has launched a lawsuit alleging that medical negligence by anaesthetist and pain specialist Dr Adnan Al-Kaisy, consultant spinal surgeon Khai Lam and the London Bridge hospital left his sister unable to move her body below the waist.

The doctors and hospital are disputing his claims.

The singer’s brother alleges that she suffered horrendous damage as a result of undergoing a procedure called epidurolysis, which is used to dissolve scar tissue around nerves in the spine.

His claim, which has been lodged at the high court in London, alleges that a series of mistakes meant “the deceased was effectively paralysed from the waist downwards, she could not walk, she could not stand even in a standing frame and she was wheelchair-bound”.

It continues: “She needed extensive care. She lived out her days in a rented apartment in New York since she could not access her home in Westchester County.”

The document claims that Al-Kaisy performed the epidurolysis despite the “limited evidence of the procedure’s efficacy, and little if any evidence of its safety”, despite the operation being little-used in the UK and the fact that it was not recommended by the National Institute of Health and Care Excellence (Nice) for back pain. It also accuses the doctor of not warning the singer of these weaknesses and not acquiring her informed consent to proceed with the procedure in those circumstances.

Norman’s brother contends that Lam also failed to warn the star about the limitations of the epidurolysis and that the procedure was the wrong treatment for the condition she was suffering from, called spinal stenosis. He claims Lam did not warn his sister “of the significant risk of paralysis arising from the procedure, in particular severe and permanent damage to the nerves involving paralysis and loss of the use of the lower part of the body”.

According to Norman his sister developed sciatica in March 2015 after undergoing surgery in New York the month before. A week later she came to London to fulfil some engagements and, on the advice of one of her doctors in her native United States, had a consultation with Lam at the London Bridge hospital. He noted that standing for a few minutes left her with pain and numbness in her right leg. He tried two treatments – steroid injections and inserting a “distraction device” – but neither relieved her symptoms.

Norman Sr’s claim says that Lam then suggested that the singer undergo epidurolysis, and suggested that Al-Kaisy could perform it. Both undertake private medical treatment and also work at Guy’s and St Thomas’ (GSTT), the leading NHS trust in London. Al-Kaisy performed the procedure at the London Bridge private hospital on 12 May 2015.

Both doctors are leading practitioners in their areas of medical expertise. Lam has regularly had articles published in medical journals and spoken at many medical conferences. The website for the GSTT’s private patient unit says that Al-Kaisy “has an international reputation as a leading expert in pain management”.

The legendary soprano was still in hospital in London after her treatment in 2015 when she first sought advice from law firm Leigh Day about taking legal action, and formally launched proceedings the next year. Her brother took over as the claimant when she died in 2019.

His claim also alleges that HCA, the giant American healthcare firm which owns and runs the London Bridge hospital, was negligent in not ensuring that the epidurolysis Lam and Al-Kaisy had recommended was safe, appropriate and evidence-based.

Olive Lewin, the specialist medical negligence solicitor at Leigh Day who is representing Norman Sr in the action, said: “The injuries Miss Norman sustained made her final years extremely difficult. It is a sad fact that despite wanting to, she was unable to continue engaging in the activities and events she loved most in the last four years of her life.

“Jessye Norman had painful sciatica, and was admitted to the London Bridge hospital for a pain-relieving procedure. She ended up being paralysed within hours of a procedure for which the claimant says there was no informed consent, and the efficacy of the procedure has not been proven.

“A negligence claim is being pursued as a result. This remains an ongoing claim, which is currently being defended.”

None of the defendants in the case responded directly to the claims when approached by the Guardian, but they are contesting the allegations against them and each has filed a defence.

HCA Healthcare UK owns and runs other private hospitals in the capital besides the London Bridge, including the Wellington, Princess Grace and Lister.

A HCA spokesperson said: “In order to ensure the confidentiality of every patient we care for, we would not comment on an inquiry into any individual’s care.”

Browne Jacobson solicitors, who are representing Al-Kaisy, said that patient confidentiality meant that he could not say anything but does deny the claims. His lawyer, Matthew Trinder, added: “I can tell you that all the allegations are strenuously denied and that a full defence has been served.”

Lam did not reply to requests to respond.

Health

Sierra Leone reports first case of monkeypox

Bayelsa confirms 13 monkeypox cases

Sierra Leone has reported its first confirmed case of mpox since the World Health Organization (WHO) raised its highest alert level for the potentially deadly viral disease last year.

According to the National Public Health Agency, the patient is a 27-year-old man from the rural district of the Western Zone, near the capital Freetown.

“Health teams are actively tracing and investigating to identify potentially exposed persons and to prevent further spread,” the agency announced in a social media post.

The confirmed case was detected on January 10, though health officials have not specified the variant affecting the patient.

Mpox, caused by a virus from the same family as smallpox, presents with high fever and skin lesions known as vesicles.

The disease was first identified in the Democratic Republic of Congo in 1970 and had mainly been limited to a dozen African countries before spreading more widely in 2022, including to regions where the virus had not previously circulated. The WHO declared its highest alert level for the disease in 2024.

In response, Sierra Leonean health authorities have swiftly activated containment measures. The infected patient has been placed in isolation while contacts will be monitored for 21 days. Surveillance efforts have been increased in all areas visited by the patient.

A public awareness campaign has been launched, and health workers are being equipped with protective gear and trained in prevention techniques to curb further spread.

Sierra Leone was previously one of the hardest-hit countries during the Ebola epidemic, which claimed around 4,000 lives, including nearly seven percent of the nation’s health workers, between 2014 and 2016.

Continue Reading

Health

Risk of HMPV infection in Nigeria moderate- NCDC

The Nigeria Centre for Disease Control (NCDC) says the risk of the human metapneumovirus (HMPV) in the country is moderate.

HMPV, which was first reported in 2001 in the Netherlands, is a single-stranded ribonucleic acid (RNA) virus that causes symptoms similar to the common cold and influenza including cough, fever, nasal congestion, and fatigue, with an incubation period of three to six days.

It causes severe complications like pneumonia in infants, the elderly, and those with weakened immune systems and spreads through respiratory droplets or contact with contaminated surfaces.

China is currently experiencing an outbreak of the virus, sparking global concern. India has also reported at least two cases of the virus.

In an advisory issued, the NCDC said the agency, in collaboration with the ministry of health, is closely monitoring global developments. The agency said as of January 6, 2025, data from surveillance does not indicate any unusual increase in respiratory infections, including those caused by HMPV.

“However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.

In collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).

The assessment classified the risk of HMPV for Nigeria as moderate. This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.”

The NCDC said it is also collaborating with port health authorities to ensure robust preparedness at all international points of entry (PoEs).

“In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required. Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols. Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.

The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI) which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted. Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.”

Continue Reading

Health

WHO declares new COVID outbreak in China global health emergency

The World Health Organization, WHO, has declared the outbreak of a new coronavirus in China, a global health emergency.

The WHO Director-General Tedros Ghebreyesus made the announcement at a press conference in Geneva.

WHO’s emergency committee on the epidemic had reportedly met Thursday afternoon and recommended designating the outbreak a Public Health Emergency of International Concern, PHEIC.

The decision had been “almost unanimous,” Didier Houssin, chair of the emergency committee, said at the press conference.

“The main reason for this declaration is not because of what is happening in China, but because of what is happening in other countries,” Tedros said at the press conference.

“Our greatest concern is the potential for the virus to spread to countries with weaker health systems and which are ill-prepared to deal with it. Let me be clear, this declaration is not a vote of no confidence in China. On the contrary, WHO continues to have confidence in China’s capacity to control the outbreak.”

Tedros also outlined recommendations made by the emergency committee to control the outbreak, including accelerating the development of vaccines and drugs and combatting the spread of misinformation.

This is the sixth time WHO has used that label, Public Health Emergency of International Concern, PHEIC. since the designation was introduced 15 years ago.

Continue Reading
Advertisement

Trending